Back to today’s briefing

Story perspectives

Trump's Tariffs on Pharmaceuticals: Security Boost or Price Spike?

4/12/2025

39 2

Summary

Story summary

President Trump is set to impose hefty tariffs on pharmaceuticals, aiming to bolster U.S. manufacturing. While supporters tout enhanced national security, critics fear rising drug prices and worsening shortages. Companies like Novartis are investing in local facilities, yet experts warn that these tariffs could disrupt supply chains and burden patients with higher costs.

History

Historical Context

President Trump's proposed tariffs on pharmaceuticals echo historical protectionist measures, like the Smoot-Hawley Tariff of 1930, which aimed to protect American industries but led to retaliatory tariffs and worsened the Great Depression. Critics warn that similar outcomes could arise, such as increased drug prices and supply chain disruptions, impacting patient access to medications in the U.S.

1 of 2

Story summary

President Trump is set to impose hefty tariffs on pharmaceuticals, aiming to bolster U.S. manufacturing. While supporters tout enhanced national security, critics fear rising drug prices and worsening shortages. Companies like Novartis are investing in local facilities, yet experts warn that these tariffs could disrupt supply chains and burden patients with higher costs.

1 / 2